A renaissance for SRC
The DOI matches its Crossref record; 117 of the 117 references it cites were found in a registry or an index.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This suggests that SRC activation may also be a dominant feature in CRC, which is supported by the observation that SRC activation was documented in > 80% of CRC [17].”
From An integrative gene expression signature analysis identifies CMS4 KRAS-mutated colorectal cancers sensitive to combined MEK and SRC targeted therapy (2022) · cites this paper as [17]
In the citing paper
“In response signaling from a variety of RTKs (including EGFR, HER2, HER4, PDGFR, VEGFR, FGFR4, GPCR, C-MET, IL-4/IL13/IL-13Rα2, IL-6ST/IL-6R/IL-11R), SRC has been reported to mediate diverse cell signaling pathways including RAS/MAPK (proliferation), PI3K/AKT (survival), FAK (adhesion/migration/EMT), and STAT3 (angiogenesis) [17, 49, 50].”
From An integrative gene expression signature analysis identifies CMS4 KRAS-mutated colorectal cancers sensitive to combined MEK and SRC targeted therapy (2022) · cites this paper as [17]
In the citing paper
“Aberrant SRC activation has been associated with a more aggressive phenotype and a worse prognosis in CRC patients [27, 28, 39].”
From Co-targeting SRC overcomes resistance to BRAF inhibitors in colorectal cancer (2025) · cites this paper as [39]
In the citing paper
“The c-src is a non-receptor protein tyrosine kinase with a 60-kD molecular weight.It is a member of a 9-gene family named the Src family kinases (SFKs)”
From The molecular rationale of Src inhibition in colorectal carcinomas (2014) · cites this paper as [1]
Citations
Cites
Integrins: Versatility, modulation, and signaling in cell adhesion
Hynes, R. O. (1992) · Cell · doi:10.1016/0092-8674(92)90115-s · Cited by 9,859 · cited 1×
“Focal adhesions are also disassembled during transformation, during which the integrity of these structures is disrupted, permitting increased motilit”
BackgroundCell Migration: A Physically Integrated Molecular Process
Lauffenburger, D. A., & Horwitz, A. F. (1996) · Cell · doi:10.1016/s0092-8674(00)81280-5 · Cited by 3,915 · cited 1×
“This is followed by release of adhesions and retraction of the rear en”
BackgroundGiancotti, F. G., & Ruoslahti, E. (1999) · Science · doi:10.1126/science.285.5430.1028 · Cited by 3,869
Creation of human tumour cells with defined genetic elements
Hahn, W. C., Counter, C. M., Lundberg, A. S., Beijersbergen, R. L., Brooks, M. W., & Weinberg, R. A. (1999) · Nature · doi:10.1038/22780 · Cited by 2,345 · cited 1×
“Although not yet reported for c- SRC , it has been possible to transform human fibroblasts with oncogenes such as HRAS when they are combined with human telomerase reverse transcriptase and the SV40 large T antige”
BackgroundTransforming gene product of Rous sarcoma virus phosphorylates tyrosine
Hunter, T., & Sefton, B. M. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.3.1311 · Cited by 2,332 · cited 1×
“v- src was subsequently shown to encode a tyrosine-specific protein kinas”
BackgroundThe STATs of cancer — new molecular targets come of age
Yu, H., & Jove, R. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1275 · Cited by 2,278 · cited 1×
“STAT3 activation by v-Src has also been shown to contribute to other biological properties of cancer cells, including cell growth and survival, and tumour-cell immune evasio”
BackgroundFOCAL ADHESIONS, CONTRACTILITY, AND SIGNALING
Burridge, K., & Chrzanowska-Wodnicka, M. (1996) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.12.1.463 · Cited by 1,942 · cited 1×
“Small adhesions can transmit stong forces for rapid movement and ultimately mature into larger focal adhesion”
BackgroundReduced cell motility and enhanced focal adhesion contact formation in cells from FAK-deficient mice
llić, D., Furuta, Y., Kanazawa, S., Takeda, N., Sobue, K., Nakatsuji, N., Nomura, S., Fujimoto, J., Okada, M., Yamamoto, T., et al. (1995) · Nature · doi:10.1038/377539a0 · Cited by 1,830
E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells.
Frixen, U. H., Behrens, J., Sachs, M., Eberle, G., Voss, B., Warda, A., Löchner, D., & Birchmeier, W. (1991) · The Journal of cell biology · doi:10.1083/jcb.113.1.173 · Cited by 1,551 · cited 1×
“Definitive studies in transgenic mice indicate that E-cadherin is an invasion suppresso”
BackgroundA causal role for E-cadherin in the transition from adenoma to carcinoma
Perl, A.-K., Wilgenbus, P., Dahl, U., Semb, H., & Christofori, G. (1998) · Nature · doi:10.1038/32433 · Cited by 1,424 · cited 1×
“and overexpression of E-cadherin can, in fact, counteract the acquisition of the invasive phenotyp”
Background
Cited by
Items 301–400 of 999
Drube, S., Stirnweiss, J., Valkova, C., & Liebmann, C. (2006) · Cellular Signalling · doi:10.1016/j.cellsig.2006.01.003 · Cited by 67
DNA Replication Stalling Attenuates Tyrosine Kinase Signaling to Suppress S Phase Progression
Shields, B. J., Hauser, C., Bukczynska, P. E., Court, N. W., & Tiganis, T. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.06.003 · Cited by 64
Zheng, X., Resnick, R. J., & Shalloway, D. (2008) · International Journal of Cancer · doi:10.1002/ijc.23321 · Cited by 60
“Src is therefore regarded as a promising therapeutic target in breast and colon cancers.(25) Unfortunately, anti-Src inhibitors frequently act on other kinases as well,(26) so obtaining sufficient therapeutic specificity may pose a challenge.”
BackgroundOncogenic signaling by tyrosine kinases of the SRC family in advanced colorectal cancer.
Sirvent, A., Bénistant, C., & Roche, S. (2012) · Europe PMC (PubMed Central) · Cited by 78
Bendinelli, P., Matteucci, E., Maroni, P., & Desiderio, M. A. (2009) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-08-0548 · Cited by 64
“The level of c-Src transducer is elevated in the most aggressive breast carcinomas (29), and seems to regulate NF-κB activity, to increase HDAC3 phosphorylation and to affect HDAC3 nuclear translocation, which may also depend on a decrease in interaction with IκBα (30-32).”
BackgroundIdentification of Targets of c-Src Tyrosine Kinase by Chemical Complementation and Phosphoproteomics
Martinez-Ferrando, I., Chaerkady, R., Zhong, J., Molina, H., Jacob, H. K. C., Herbst, K. J., Rabbitts, B. M., Katju, V., Bose, R., Zhang, J., et al. (2012) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m111.015750 · Cited by 70
“matrix adhesion (focal adhesions) (1).”
BackgroundSrc Induces Podoplanin Expression to Promote Cell Migration
Shen, Y., Chen, C.-S., Ichikawa, H., & Goldberg, G. S. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.047696 · Cited by 62
Schilder, R. J., Brady, W. E., Lankes, H. A., Fiorica, J. V., Shahin, M. S., Zhou, X. C., Mannel, R. S., Pathak, H. B., Hu, W., Alpaugh, R. K., et al. (2012) · Gynecologic Oncology · doi:10.1016/j.ygyno.2012.06.009 · Cited by 60
“SRC is a component of signaling pathways downstream of many growth factor 33 receptors, including epidermal growth factor receptor (EGFR), vascular endothelial growth factor 34 receptor (VEGFR), and MNNG transforming gene product (c-MET) [4].”
BackgroundLiu, W., Kovačević, Ž., Peng, Z., Jin, R., Wang, P., Yue, F., Zheng, M., Huang, M., Jansson, P. J., Richardson, V., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.5849 · Cited by 65
“Considering that p120-catenin anchors E-cadherin to the actin cytoskeleton via α-catenin (Figure 3) [16, 106, 107], activation of SFKs disrupts these crucial bonds and leads to the rapid internalization of E-cadherin [16, 42, 95].”
BackgroundSrc Inhibitors in Lung Cancer: Current Status and Future Directions
Rothschild, S. I., Gautschi, O. P., Haura, E. B., & Johnson, F. M. (2010) · Clinical Lung Cancer · doi:10.3816/clc.2010.n.030 · Cited by 59
Liu, C., Li, Y., Xing, Y., Cao, B., Yang, F., Yang, T., Ai, Z., Wei, Y., & Jiang, J. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.712976 · Cited by 66
“Src is highly expressed or highly activated in various human cancers (27).”
BackgroundEnomoto, M., Siow, K. M., & Igaki, T. (2018) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-0529-0_10 · Cited by 70
Camiña, J. P., Lodeiro, M., Ischenko, O. P., Martini, A. C., & Casanueva, F. F. (2007) · Journal of Cellular Physiology · doi:10.1002/jcp.21109 · Cited by 63
“…either decreased Tyr527-directed kinase activity or increased Tyr527-directed JOURNAL OF CELLULAR PHYSIOLOGY DOI 10.1002/JCP G H R E L I N S I G N A L I N G T O E R K 1 / 2 197 198 C A M I Ñ A E T A L . phosphatase activity (Thomas and Brugge, 1997; Frame, 2002; Yeatman, 2004; Roskoski, 2005).”
BackgroundInfluentialZarif, J. C., Lamb, L. E., Schulz, V. V., Nollet, E. A., & Miranti, C. K. (2015) · Oncotarget · doi:10.18632/oncotarget.3119 · Cited by 69
“Src is a major effector of cell spreading, migration, and invasion [19, 20].”
BackgroundEndosomal NADPH oxidase regulates c-Src activation following hypoxia/reoxygenation injury
Li, Q., Zhang, Y., Marden, J. J., Banfi, B., & Engelhardt, J. F. (2008) · Biochemical Journal · doi:10.1042/bj20071534 · Cited by 58
Targeting Src signaling in metastatic bone disease
Araujo, J., & Logothetis, C. (2009) · International Journal of Cancer · doi:10.1002/ijc.23998 · Cited by 58
“(SFKs), a family of 9 similar proteins that also includes Blk, Fgr, Fyn, Hck, Lck, Lyn, Yes and Yrk.(4,5) SFK members share a unique”
BackgroundInfluentialCastro‐Sánchez, L., Soto-Guzmán, A., Guaderrama-Díaz, M., Cortés‐Reynosa, P., & Salazar, E. P. (2011) · Clinical & Experimental Metastasis · doi:10.1007/s10585-011-9385-9 · Cited by 60
“The Src family of non-receptor tyrosine kinases plays an important role in a variety of cell processes including cell cycle progression, growth, survival and migration [76, 77].”
BackgroundFlorio, A. D., Capurso, G., Milione, M., Panzuto, F., Geremia, R., Fave, G. D., & Sette, C. (2007) · Endocrine Related Cancer · doi:10.1677/erc.1.01318 · Cited by 63
“Interestingly, in several cell types, FAK directly recruits Src to the focal adhesion sites (Schaller et al. 1994, Thomas et al. 1998) and Src potentiates activation of FAK through phosphorylation of additional tyrosine residues (Schlaplafer et al. 1994, Calalb et al. 1995 ).”
BackgroundFyn deficiency attenuates renal fibrosis by inhibition of phospho-STAT3
Seo, H.-Y., Jeon, J., Jung, Y., Jung, G., Lee, E. J., Choi, Y., Park, K., Choe, M. S., Jang, B. K., Kim, M. K., et al. (2016) · Kidney International · doi:10.1016/j.kint.2016.06.038 · Cited by 60
Sebé-Pedrós, A., Peña, M. I., Capella-Gutiérrez, S., Antó, M., Gabaldón, T., Ruiz-Trillo, I., & Sabidó, E. (2016) · Developmental Cell · doi:10.1016/j.devcel.2016.09.019 · Cited by 65
Src42A modulates tumor invasion and cell death via Ben/dUev1a-mediated JNK activation in Drosophila
Ma, X., Shao, Y., Zheng, H., Li, M., Li, W., & Xue, L. (2013) · Cell Death and Disease · doi:10.1038/cddis.2013.392 · Cited by 60
Zhang, H., Su, L., Müller, S., Tighiouart, M., Xu, Z., Zhang, X., Shin, H. J. C., Hunt, J. L., Sun, S.-Y., Shin, D. M., et al. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604735 · Cited by 57
“The pivotal roles of Src in cell growth and metastasis has been well established (Yeatman, 2004).”
BackgroundProtoporphyrin IX-dependent photodynamic production of endogenous ROS stimulates cell proliferation
Blázquez‐Castro, A., Carrasco, E., Calvo-Sánchez, M. I., Jaén, P., STOCKERT, J. C., Juarranz, Á., Sanz-Rodríguez, F., & Espada, J. (2012) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2011.12.001 · Cited by 60
Parasassi, T., Brunelli, R., Bracci‐Laudiero, L., Greco, G., Gustafsson, A. C., Krasnowska, E. K., Lundeberg, J., Lundeberg, T., Pittaluga, E., Romano, M.-C., et al. (2005) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401663 · Cited by 65
Differing Src Signaling Levels Have Distinct Outcomes in Drosophila
Vidal, M., Warner, S., Read, R., & Cagan, R. L. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1376 · Cited by 57
“activation by receptor tyrosine kinases such as epidermal growth factor receptor (EGFR) and HER2 (37); and/or (d) a strong increase in Src expression levels (35).”
BackgroundInfluentialKim, S., Yang, X.-K., Li, Q., Wu, M., Costyn, L., Beharry, Z., Bartlett, M., & Cai, H.-J. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.798827 · Cited by 51
“Src kinase is a pleiotropic activator in numerous signal transduction pathways, including the MAPK, PI3K–Akt, integrin–FAK, and STAT3 pathways, consequently leading to cell survival, proliferation, migration, tumor adhesion, and angiogenesis (3).”
BackgroundRaju, U., Riesterer, O., Wang, Z., Molkentine, D. P., Molkentine, J. M., Johnson, F. M., Glisson, B. S., Milas, L., & Ang, K. K. (2012) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2012.08.010 · Cited by 62
“c-Src kinase belongs to a family of non-receptor kinases that are involved in a number of signaling pathways that control cell survival, cell cycle progression, cell proliferation, angiogenesis, cell adhesion and motility [2–5].”
Xie, W., Liu, Z., Fang, D., Wu, W., Ma, S., Tan, S., & Zheng, K. (2019) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2019.02.071 · Cited by 58
The role of Src family kinases in growth and migration of glioma stem cells
Han, X., Zhang, W., Yang, X., Wheeler, C. G., Langford, C. P., Wu, L., Filippova, N., Friedman, G. K., Ding, Q., Fathallah‐Shaykh, H. M., et al. (2014) · International Journal of Oncology · doi:10.3892/ijo.2014.2432 · Cited by 66
“The role of SFKs in glioma development and progression was demonstrated in transgenic mice of v-Src, a constitutively active mutant of Src (11-13).”
BackgroundJung, J., Kim, H.-J., Kim, M., Sohn, K.-B., Kim, M., & Lee, K. (2011) · Oncogene · doi:10.1038/onc.2010.604 · Cited by 58
“In addition to cell proliferation, Src also regulates other cellular functions, including cell adhesion, motility and invasion, which change the cell behavior, ultimately contributing to the tumor progression and metastasis (Yeatman, 2004).”
BackgroundSankar, S., Tanner, J. M., Bell, R. N., Chaturvedi, A. P., Randall, R. L., Beckerle, M. C., & Lessnick, S. L. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.00241-13 · Cited by 57
“Activated mutants of Src play a role in oncogenic transformation and affect morphological changes, including cellular adhesion (63).”
BackgroundIsmail, N. S. M., Ali, G., Ibrahim, D. A., & Elmetwally, A. M. (2016) · Future Journal of Pharmaceutical Sciences · doi:10.1016/j.fjps.2016.08.004 · Cited by 60
Azimifar, S. B., Böttcher, R. T., Zanivan, S., Grashoff, C., Krüger, M., Legate, K. R., Mann, M., & Fässler, R. (2012) · Journal of Cell Science · doi:10.1242/jcs.091652 · Cited by 54
“Src activity is regulated by both integrin and RTK signalling (Huveneers and Danen, 2009; Yeatman, 2004), and precise spatiotemporal activation is important for its biological functions, including the regulation of FA stability, turnover and integrity”
BackgroundThe importance of non-nuclear AR signaling in prostate cancer progression and therapeutic resistance
Zarif, J. C., & Miranti, C. K. (2016) · Cellular Signalling · doi:10.1016/j.cellsig.2016.01.013 · Cited by 62
“Src is a cytosolic 60 kDa protein composed of seven functional domains: a myristoylated aminoterminus, a unique domain specific to each SFK member, a Src homology domain 3 (SH3), Src homology domain 2 (SH2), a linker region, a catalytic domain, and a COOH-terminal tail [119, 120].”
Lin, C., Wang, S., Xie, W., Zheng, R., Gan, Y., & Chang, J. (2016) · Oncotarget · doi:10.18632/oncotarget.10985 · Cited by 60
Src‐mediated crosstalk between FXR and YAP protects against renal fibrosis
Kim, D., Choi, H., Park, J. S., Kim, C. S., Bae, E. H., Kwon, S., & Kim, S. W. (2019) · The FASEB Journal · doi:10.1096/fj.201900325r · Cited by 59
“Src kinase plays an important role in cell proliferation, differentiation,migration, and immune response (37), and it is a critical mediator of renal fibrosis (33, 38).”
BackgroundTranslational evidence on the role of Src kinase and activated Src kinase in invasive breast cancer
Elsberger, B. (2014) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2013.12.009 · Cited by 54
“The Src family comprises lk, Fgr, Fyn, Hck, Lck, Lyn, Src, and Yes (alphabetically isted) [2].”
BackgroundInfluentialPyrazolo[3,4-d]pyrimidine based scaffold derivatives targeting kinases as anticancer agents
Ismail, N. S. M., Ali, E. M. H., Ibrahim, D. A., Serya, R. A. T., & Ella, D. A. A. E. (2016) · Future Journal of Pharmaceutical Sciences · doi:10.1016/j.fjps.2016.02.002 · Cited by 60
HGF and c-MET as potential orchestrators of invasive growth in head and neck squamous cell carcinoma
de Herdt, M. (2007) · Frontiers in bioscience · doi:10.2741/2863 · Cited by 54
Han, J., Shuvaev, V. V., Davies, P. F., Eckmann, D. M., Muro, S., & Muzykantov, V. R. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.05.006 · Cited by 56
“SFKs are signaling enzymes regulating cellular proliferation, survival, migration and metastasis [54,55].”
BackgroundPortillo, J. C., Muniz-Feliciano, L., Corcino, Y. L., Lee, S. J., Grol, J. V., Parsons, S. J., Schiemann, W. P., & Subauste, C. S. (2017) · PLoS Pathogens · doi:10.1371/journal.ppat.1006671 · Cited by 58
Ahmed, H. E. A., El-Nassag, M. A. A., Hassan, A. A. E.-H., Mohamed, H. M., Halawa, A. H., Okasha, R. M., Ihmaid, S. K., El-Gilil, S. M. A., Khattab, E. S. A. E. H., Fouda, A. M., et al. (2019) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2019.03.012 · Cited by 54
Encyclopedia of Signaling Molecules
Choi, S. (2012) · Springer eBooks · doi:10.1007/978-1-4419-0461-4 · Cited by 54
Poh, A. R., & Ernst, M. (2023) · Oncogene · doi:10.1038/s41388-023-02701-x · Cited by 60
“Subsequently, auto-phosphorylation of YA results in full SFK activation [22].”
BackgroundMacKay, H. J., Au, H., McWhirter, E., Alcindor, T., Jarvi, A., MacAlpine, K., Wang, L. E., Wright, J. J., & Oza, A. M. (2011) · Investigational New Drugs · doi:10.1007/s10637-011-9650-4 · Cited by 56
“Dysregulation of Src has been implicated in carcinogenesis and tumor progression, mediating processes such as cellular adhesion, invasion, motility and migration [8, 9].”
BackgroundDasatinib treatment for Philadelphia chromosome‐positive leukemias
Khoury, H. J., Guilhot, F., Hughes, T. P., Kim, D., & Cortes, J. E. (2009) · Cancer · doi:10.1002/cncr.24155 · Cited by 53
“In addition, dasatinib inhibition of Src family kinases (Src or Yes) may increase the permeability of pleural/pulmonary vasculature through the inhibition of cell-cell adhesion or vascular endothelial growth factor-induced responses.(35,39,40) However, other dual Bcr-Abl/Src inhibitors, such as bosutinib, have not bee…”
BackgroundPan‐Src Family Kinase Inhibitors Replace Sox2 during the Direct Reprogramming of Somatic Cells
Staerk, J., Lyssiotis, C. A., Medeiro, L. A., Bollong, M. J., Foreman, R. K., Zhu, S., Garcia, M. E., Gao, Q., Bouchez, L. C., Lairson, L. L., et al. (2011) · Angewandte Chemie International Edition · doi:10.1002/anie.201101042 · Cited by 55
Jin, Y., Cai, Q., Shenoy, A. K., Lim, S., Zhang, Y., Charles, S., Tarrash, M., Fu, X., Kamarajugadda, S., Trevino, J. G., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.7159 · Cited by 60
“Src, a nonreceptor tyrosine kinase, is the most widely known and the prototypical member of the Src family of tyrosine kinases (SFKs) [20, 21].”
Megakaryopoiesis and Thrombopoiesis: An Update on Cytokines and Lineage Surface Markers
Yu, M., & Cantor, A. B. (2011) · Methods in molecular biology · doi:10.1007/978-1-61779-307-3_20 · Cited by 53
Parkin, A., Man, J., Timpson, P., & Pajic, M. (2019) · FEBS Journal · doi:10.1111/febs.15011 · Cited by 58
Src Kinase Phosphorylates RUNX3 at Tyrosine Residues and Localizes the Protein in the Cytoplasm
Goh, Y., Cinghu, S., Hong, E. T. H., Lee, Y., Kim, J., Jang, J., Li, Y., Chi, X., Lee, K., Wee, H., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.071381 · Cited by 53
Saeed, M. E. M., Jacob, S., Sandjo, L. P., Sugimoto, Y., Khalid, H. E., Opatz, T., Thines, E., & Efferth, T. (2015) · Frontiers in Pharmacology · doi:10.3389/fphar.2015.00267 · Cited by 57
“Both SLs silenced c-Src phosphorylation, which represents an interesting approach for Frontiers in Pharmacology | www.frontiersin.org 9 November 2015 | Volume 6 | Article 267 targeted therapy, because c-Src is activated in many human cancers (Yeatman, 2004).”
BackgroundMethodInfluentialImproving the prognosis for patients with glioblastoma: the rationale for targeting Src
de Groot, J., & Milano, V. (2009) · Journal of Neuro-Oncology · doi:10.1007/s11060-009-9916-2 · Cited by 59
“MMPs are known to degrade the ECM, releasing angiogenic factors and promoting cellular invasion.”
BackgroundMethodInfluentialNaudin, C., Sirvent, A., Leroy, C., Larive, R. M., Simon, V., Pannequin, J., Bourgaux, J., Pierre, J., Robert, B., Hollande, F., et al. (2014) · Nature Communications · doi:10.1038/ncomms4159 · Cited by 55
Rafinejad, A., Fallah‐Tafti, A., Tiwari, R. K., Shirazi, A. N., Mandal, D., Shafiee, A., Parang, K., Foroumadi, A., & Akbarzadeh, T. (2012) · DARU Journal of Pharmaceutical Sciences · doi:10.1186/2008-2231-20-100 · Cited by 53
“c-Src acts as a critical component in a number of signaling pathways that control cell growth, proliferation, invasion, and apoptosis [1-3].”
BackgroundWang, N., Li, Q., Feng, N., Cheng, G., Guan, Z.-L., Wang, Y., Qin, C., Yin, C., & Hua, L. X. (2013) · Asian Journal of Andrology · doi:10.1038/aja.2013.80 · Cited by 59
Sun, J., Wang, X., Tang, B., Liu, H., Zhang, M., Wang, Y., Ping, F., Ding, J., Shen, A., & Geng, M. (2018) · Theranostics · doi:10.7150/thno.23964 · Cited by 52
“The AKT, MAPK and STAT pathways are the other well-documented down-stream components that are regulated by Src signaling to control cell proliferation [31, 32].”
Finn, R. S., Aleshin, A. A., Dering, J., Yang, P. C., Ginther, C., Desai, A. J., Zhao, D., von Euw, E., Busuttil, R. W., & Slamon, D. J. (2013) · Hepatology · doi:10.1002/hep.26223 · Cited by 67
“c-SRC encodes a nonreceptor tyrosine kinase that, when activated, is involved in several pathways associated with oncogenesis including cellular proliferation, survival, migration, and angiogenesis.(19) In HCC specifically, increased SRC activity has been described(20-22) and in some studies has been correlated with a…”
BackgroundDesmoglein 3: A Help or a Hindrance in Cancer Progression?
Brown, L., & Wan, H. (2015) · Cancers · doi:10.3390/cancers7010266 · Cited by 53
“normal cell homeostasis through the regulation of various functions including proliferation, adhesion, differentiation, gene transcription, cytoskeletal alterations and migration [89–91].”
BackgroundERK5 promotes Src-induced podosome formation by limiting Rho activation
Schramp, M., Ying, O., Kim, T. Y., & Martin, G. S. (2008) · The Journal of Cell Biology · doi:10.1083/jcb.200801078 · Cited by 56
“Src activity is elevated in some epithelial cancers, and the extent of activation correlates with metastatic ability ( Frame, 2002 ; Yeatman, 2004 ).”
The T-LAK Cell-originated Protein Kinase Signal Pathway Promotes Colorectal Cancer Metastasis
Zykova, T. A., Zhu, F., Wang, L., Li, H., Bai, R., Lim, D. Y., Yao, K., Bode, A. M., & Dong, Z. (2017) · EBioMedicine · doi:10.1016/j.ebiom.2017.04.003 · Cited by 51
“, 2000), Src pathway (Yeatman, 2004) and the Akt pathway (Irie et al.”
BackgroundIGF2BP1 is a targetable SRC/MAPK-dependent driver of invasive growth in ovarian cancer
Bley, N., Schott, A., Müller, S., Misiak, D., Lederer, M., Fuchs, T., Aßmann, C., Glaß, M., Ihling, C. H., Sinz, A., et al. (2020) · RNA Biology · doi:10.1080/15476286.2020.1812894 · Cited by 51
“lecular interaction (closed conformation) [43].”
Tapia, M., Hernándo, C., Martínez, M. T., Burgués, O., Tebar, C., Lameirinhas, A., Ágreda‐Roca, A., Torres‐Ruiz, S., Garrido‐Cano, I., Lluch, A. M., et al. (2023) · Cancers · doi:10.3390/cancers15184522 · Cited by 58
“Src is a proto-oncogene that encodes the non-receptor protein tyrosine kinase Src, which plays a critical role in several cellular processes and promotes cell proliferation and survival [33].”
BackgroundLiang, F.-P., Lin, C., Kuo, C., Chao, H., & Fu, S.-L. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m705877200 · Cited by 52
Loss of Androgen-Regulated MicroRNA 1 Activates SRC and Promotes Prostate Cancer Bone Metastasis
Liu, Y.-N., Yin, J., Barrett, B., Sheppard-Tillman, H., Li, D., Casey, O. M., Fang, L., Hynes, P. G., Ameri, A. H., & Kelly, K. (2015) · Molecular and Cellular Biology · doi:10.1128/mcb.00008-15 · Cited by 49
“SRC is a nonreceptor tyrosine kinase that is thought to integrate numerous signaling pathways, including AR (11, 12).”
BackgroundThe tetraspanin CD151 regulates cell morphology and intracellular signaling on laminin‐511
Yamada, M., Sumida, Y., Fujibayashi, A., Fukaguchi, K., Sanzen, N., Nishiuchi, R., & Sekiguchi, K. (2008) · FEBS Journal · doi:10.1111/j.1742-4658.2008.06481.x · Cited by 50
Armstrong, A. J., & Febbo, P. G. (2009) · The Oncologist · doi:10.1634/theoncologist.2009-0043 · Cited by 51
Birkl, D., Quirós, M., García‐Hernández, V., Zhou, D. W., Brazil, J. C., Hilgarth, R., Keeney, J. N., Yulis, M., Bruewer, M., García, A. J., et al. (2019) · Mucosal Immunology · doi:10.1038/s41385-019-0150-8 · Cited by 50
Kohlmaier, A., Fassnacht, C., Jin, Y., Reuter, H., Begum, J., Dutta, D., & Edgar, B. A. (2014) · Oncogene · doi:10.1038/onc.2014.163 · Cited by 52
Role of Erbin in ErbB2-dependent breast tumor growth
Tao, Y., Shen, C., Luo, S., Traoré, W., Marchetto, S., Santoni, M.-J., Xu, L., Wu, B., Shi, C., Mei, J., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1407139111 · Cited by 56
“We examined phosphorylation of Src Y416 and Y527, the phosphorylation of which indicates activation and inactivation of the kinase, respectively (30).”
MethodThapa, N., Choi, S., Tan, J. X., Wise, T., & Anderson, R. A. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.596742 · Cited by 54
“By virtue of its SH2 and SH3 domains, Src interacts with different signaling molecules and modulates their functionality (34, 51).”
BackgroundHuang, W., Zhu, X., Wang, Y., Azam, M., Wen, D. J., Sundaramoorthi, R., Thomas, R. M., Liu, S., Banda, G., Lentini, S. P., et al. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm900166t · Cited by 49
Bhole, R. P., Kute, P. R., Chikhale, R. V., Bonde, C. G., Pant, A., & Gurav, S. S. (2023) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2023.106720 · Cited by 53
Torres‐Ayuso, P., Daza-Martín, M., Martín-Pérez, J., Ávila‐Flores, A., & Mérida, I. (2014) · Oncotarget · doi:10.18632/oncotarget.2344 · Cited by 54
“These modulators include upstream RTK, kinases and phosphatases that regulate Src conformation, as well as substrates that unclamp closed/inactive Src and lead to an open/active state [20, 63-65].”
BackgroundAkita, K., Minami, T., Tanida, S., Mori, Y., Toda, M., & Nakada, H. (2013) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2013.10.005 · Cited by 48
Doubles game: Src-Stat3 versus p53-PTEN in cellular migration and invasion
Mukhopadhyay, U. K., Mooney, P., Jia, L., Eves, R., Raptis, L., & Mak, A. S. (2010) · Molecular and Cellular Biology · doi:10.1128/mcb.00004-10 · Cited by 48
“Src, a proto-oncogenic nonreceptor tyrosine kinase, induces migratory and invasive phenotypes in various cell types by initiating extensive cytoskeletal rearrangements (38, 51, 67).”
BackgroundThe molecular rationale of Src inhibition in colorectal carcinomas
Gargalionis, A. N., Karamouzis, M. V., & Papavassiliou, A. G. (2014) · International Journal of Cancer · doi:10.1002/ijc.28299 · Cited by 47
“These two conformational alterations set csrc protein in a closed configuration that “hides” the SH1 kinase domain and reduces the potential for substrate interactions.(1) Mutations, C-terminal tail dephosphorylation and displacement of the inhibitory protein interactions disrupt either SH2-tail or SH3-linker associat…”
BackgroundSRC Signaling in Cancer and Tumor Microenvironment
Caner, A., Aşık, E., & Özpolat, B. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-47189-7_4 · Cited by 52
Wan, X., Yeung, C. L., Heske, C. M., Mendoza, A., & Helman, L. J. (2015) · Neoplasia · doi:10.1016/j.neo.2015.03.001 · Cited by 49
“Several SFK inhibitors, such as dasatinib, AZD0530, and SKI-606, are entering clinical trials as anticancer therapeutics [9].”
BackgroundFunctional dissection of transformation by c‐Src and v‐Src
Oneyama, C., Hikita, T., Nada, S., & Okada, M. (2007) · Genes to Cells · doi:10.1111/j.1365-2443.2007.01145.x · Cited by 50
“…of v-Src differs from that of c-Src in that v-Src lacks the regulatory C-terminal domain of c-Src and has several point mutations, both of which coordinately render v-Src constitutively active and confer a high transformation activity (Takeya & Hanafusa 1982; Jove & Hanafusa 1987; Yeatman 2004).”
BackgroundInfluentialRack1 promotes epithelial cell–cell adhesion by regulating E-cadherin endocytosis
Swaminathan, G., & Cartwright, C. A. (2011) · Oncogene · doi:10.1038/onc.2011.242 · Cited by 54
“For instance, Src regulates various facets of signaling to AJs as well as E-cadherin stability, and is a key contributor to epithelial–mesenchymal transition, which drives tumor metastasis (Frame, 2004; Yeatman, 2004).”
BackgroundNoronha, G., Barrett, K., Boccia, A., Brodhag, T., Cao, J., Chow, C. P., Dneprovskaia, E., Doukas, J., Fine, R., Gong, X., et al. (2006) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2006.11.006 · Cited by 49
Ramírez, D., Saba, J., Carniglia, L., Durand, D., Lasaga, M., & Caruso, C. M. (2015) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2015.04.008 · Cited by 47
“Src integrates and regulates survival signals from tyrosine kinase receptors and activates the PI3K/Akt pathway (Yeatman, 2004) as well as the ERK pathway (Liebmann, 2001).”
Wilson, A. L., Schrecengost, R. S., Guerrero, M. S., Thomas, K. S., & Bouton, A. H. (2013) · PLoS ONE · doi:10.1371/journal.pone.0065678 · Cited by 46
“Like BCAR3, these molecules are established regulators of cell motility, antiestrogen resistance, and other aggressive breast cancer behaviors [34,35,36,37,38,39].”
BackgroundMin, H., Yun, H. J., Lee, J., Lee, H., Cho, J., Jang, H.-J., Park, S., Liu, D., Oh, S.-H., Lee, J. J., et al. (2015) · Molecular Cancer · doi:10.1186/s12943-015-0392-3 · Cited by 47
“Previous reports suggested that Src can directly phosphorylate IGF-1R at the sites of ligand-induced autophosphorylation [12, 13].”
Differential Sensitivity of Src-Family Kinases to Activation by SH3 Domain Displacement
Moroco, J. A., Craigo, J. K., Iacob, R. E., Wales, T. E., Engen, J. R., & Smithgall, T. E. (2014) · PLoS ONE · doi:10.1371/journal.pone.0105629 · Cited by 46
“Increased c-Src expression and activity are both observed in many forms of cancer and contribute to tumor cell proliferation, migration, and invasiveness [3].”
BackgroundMicroRNA-106a targets autophagy and enhances sensitivity of lung cancer cells to Src inhibitors
Rothschild, S. I., Gautschi, O. P., Batliner, J., Gugger, M., Fey, M. F., & Tschan, M. P. (2016) · Lung Cancer · doi:10.1016/j.lungcan.2016.06.004 · Cited by 48
Castoria, G., Auricchio, F., & Migliaccio, A. (2016) · The FASEB Journal · doi:10.1096/fj.201601047r · Cited by 45
“In addition to cell proliferation, Src influences adhesion and migration by interacting with actin, FAK, and integrins (16, 17); therefore, in addition to reducing cell proliferation, Src inhibitors (for example, saracatinib, dasatinib, and bosutinib) affect adhesion and migration of prostate cancer cells cultured inv…”
BackgroundChen, C., Shenoy, A. K., Padia, R. N., Fang, D., Jing, Q., Yang, P., Su, S.-B., & Huang, S. (2018) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-018-0902-4 · Cited by 48
Reversion-induced LIM interaction with Src reveals a novel Src inactivation cycle
Zhang, Y., Tu, Y., Zhao, J., Chen, K., & Wu, C. (2009) · The Journal of Cell Biology · doi:10.1083/jcb.200810155 · Cited by 48
“…PP2, a pyrazolo pyrimidine-type inhibitor that is known to lock Src in an inactive conformation Src is known to play a role in the regulation of anchorageindependent growth ( Summy and Gallick, 2003 , 2006 ; Frame, 2004 ; Playford and Schaller, 2004 ; Russello and Shore, 2004 ; Yeatman, 2004 ).”
Gilleron, J., Carette, D., Fiorini, C., Dompierre, J., Macia, E., Denizot, J., Segretain, D., & Pointis, G. (2011) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2011.04.014 · Cited by 45
Src Family Kinases Promote Silencing of ATR-Chk1 Signaling in Termination of DNA Damage Checkpoint
Fukumoto, Y., Morii, M., Miura, T., Kubota, S., Ishibashi, K., Honda, T., Okamoto, A., Yamaguchi, N., Iwama, A., Nakayama, Y., et al. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.533752 · Cited by 49
Liu, S., Chen, S., Li, X., Wu, S., Zhang, Q., Jin, Q., Hu, L. T., Zhou, R., Yu, Z., Meng, F., et al. (2017) · Cell Host & Microbe · doi:10.1016/j.chom.2017.05.010 · Cited by 46
Emergence of Nanotechnology as a Powerful Cavalry against Triple-Negative Breast Cancer (TNBC)
Chaudhuri, A., Kumar, D. N., Dehari, D., Singh, S. P., Kumar, P., Bolla, P. K., Kumar, D. K., & Agrawal, A. K. (2022) · Pharmaceuticals · doi:10.3390/ph15050542 · Cited by 54
“Src is a non-receptor tyrosine kinase that is involved in various signal transductions, including cell proliferation and cell invasion [178,179].”
BackgroundEichhorn, P. J. A., Creyghton, M. P., Wilhelmsen, K., van Dam, H., & Bernards, R. (2007) · PLoS Genetics · doi:10.1371/journal.pgen.0030218 · Cited by 45
“c-SRC is overexpressed or activated in a wide variety of tumors [5,6].”
Nuclear localization of Lyn tyrosine kinase mediated by inhibition of its kinase activity
Ikeda, K., Nakayama, Y., Togashi, Y., Obata, Y., Kuga, T., Kasahara, K., Fukumoto, Y., & Yamaguchi, N. (2008) · Experimental Cell Research · doi:10.1016/j.yexcr.2008.08.019 · Cited by 54
“Overexpression and enhanced activity of Srcfamily kinases found in a large number of human malignancies have been linked to the development of cancer and progression to metastases [6,7], and there has recently been a”
BackgroundDrosophila ASPP Regulates C-Terminal Src Kinase Activity
Langton, P. F., Colombani, J., Aerne, B. L., & Tapon, N. (2007) · Developmental Cell · doi:10.1016/j.devcel.2007.11.005 · Cited by 52
Israeli, S., Amsler, K., Zheleznova, N. N., & Wilson, P. D. (2009) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00032.2009 · Cited by 45
“The Y861 site was only phosphorylated in the steady state in both HFCT and ARPKD epithelia, suggesting this was not a significant early activation event during focal contact assembly although we cannot rule out a compensatory activation of FAK by phosphorylation at the c-Src Y576/577 activation site.”
BackgroundInfluentialMizrachy‐Schwartz, S., Cohen, N., Klein, S., Kravchenko‐Balasha, N., & Levitzki, A. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.211813 · Cited by 47
HD-PTP inhibits endothelial migration through its interaction with Src
Mariotti, M., Castiglioni, S., García-Manteiga, J. M., Beguinot, L., & Maier, J. A. M. (2008) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2008.08.005 · Cited by 53
Metadata
- Authors
- Yeatman, T. J.
- Affiliations
- Moffitt Cancer Center (US)
- Corresponding author
- Yeatman, Timothy J.
- ORCID
- Yeatman, Timothy J.
- Venue
- Nature Reviews Cancer
- Published
- 2004-06-01
- Volume
- 4
- Issue
- 6
- Pages
- 470-480
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W2036988959
- Cited by
- 1,113
- References
- 115
- Citations by year
- 2026: 17 · 2025: 21 · 2024: 20 · 2023: 43 · 2022: 43 · 2021: 46 · 2020: 44 · 2019: 39 · 2018: 49 · 2017: 44 · 2016: 69 · 2015: 56 · 2014: 72 · 2013: 79 · 2012: 73
- FWCI
- 5.40
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature reviews. Cancer (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Mechanisms and Therapy
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mechanisms of cancer metastasis
- Keywords
- Src kinase, non-receptor tyrosine kinase, cancer, metastasis, cell invasion, cell motility, cell proliferation, anticancer agents, tumor progression
- MeSH terms
- Antineoplastic Agents, Cell Division, Humans, Neoplasm Invasiveness, Neoplasm Metastasis, Neoplasms, Neovascularization, Pathologic, Phenotype, Gene Expression Regulation, Neoplastic, Genes, src, Disease Progression
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.